Ben Ho Park

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a three-year grant to support research led by Houra Merrikh, PhD, professor of Biochemistry, and Ben Ho Park, MD, PhD, the Benjamin F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, to create an anti-evolution drug to reduce the capacity of cancer cells to develop resistance. Read More

Vanderbilt University has selected 11 prominent faculty members who have distinguished themselves as pioneers and leaders in their fields to receive endowed chairs. Read More

Vanderbilt’s Health Professions Advisory Office, in collaboration with faculty at Vanderbilt-Ingram Cancer Center, gave a group of undergraduate students a firsthand look at how physicians approach specialized cancer treatment. The students were given the opportunity to participate in a series of virtual “tumor boards.” Read More

Breast cancer expert Ben Ho Park, M.D., is the new director of Precision Oncology at Vanderbilt-Ingram Cancer Center. Dr. Park explains his groundbreaking research on the genetic events that lead to cancer, and what that means for the future of cancer treatment. Read More

Vanderbilt’s six newest endowed chairs were honored by colleagues, university leaders, family members and donors at a ceremony on April 30 in the Student Life Center. Read More

  Internationally renowned breast cancer expert Ben Ho Park, MD, PhD, has been named co-leader of the Breast Cancer Research Program, director of Precision Oncology and associate director for Translational Research at Vanderbilt-Ingram Cancer Center. In his academic role, he will serve as professor of Medicine. Ben Ho Park, MD,… Read More